StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) shareholders

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
7.5%
0M of 1M shares
Institutional holders
18
8 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Ashkan Mapar
Joint filing with Alumni Capital LP (9.58%), Alumni Capital GP LLC (9.58%)
781,1109.58%13G (passive)Sep 4, 2025
Intracoastal Capital LLC
Joint filing with Mitchell P. Kopin (7.70%), Daniel B. Asher (7.70%)
576,6037.70%13G (passive)Sep 4, 2025
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
84,4969.99%13G (passive)Dec 31, 2025
Jane Street Group, LLC35,8195.00%13G (passive)Oct 6, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of AEMDValueChange% of portfolio
Hrt Financial LP14,5492.05%$59.00KNew0.00%
Citadel Advisors LLC8,5951.21%$35.39KNew0.00%
Jane Street Group, LLC7,7761.09%$32.01KNew0.00%
Shay Capital LLC6,2140.87%$25.59K+3,3890.00%
Virtu Financial LLC5,5630.78%$23.00KNew0.00%
Ikarian Capital, LLC2,8730.40%$11.83K–0.00%
Geode Capital Management, LLC2,0380.29%$8.39K−2,8350.00%
Scientech Research LLC2,0110.28%$8.28KNew0.01%
UBS Group AG1,7750.25%$7.31K+1,5960.00%
Tower Research Capital LLC (TRC)1,2660.18%$5.21K+9440.00%
Morgan Stanley4940.07%$2.04K+850.00%
Jones Financial Companies Lllp30.00%$15New0.00%
Integrated Wealth Concepts LLC30.00%$12New0.00%
Group One Trading, L.P.30.00%$12–0.00%
BlackRock, Inc.20.00%$8–0.00%
Wells Fargo & Company/Mn10.00%$2–0.00%
Northwestern Mutual Wealth Management Co00.00%$2New0.00%
Danske Bank A/S00.00%$1–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026180M7.5%8 / 41 / 20M0M
Q1 2026120M2.0%6 / 00 / 20M0M
Q4 202580M0.5%8 / 00 / 10M0M
Q3 202510M0.0%1 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
James B. FrakesCFO/CEO, Director42,0635.91%Oct 13, 2026
Steven P. LarosaChief Medical Officer42,0575.91%Oct 15, 2026
Chetan ShahDirector3,7870.53%Oct 15, 2026
Nicolas GikakisDirector3,7840.53%Oct 15, 2026
Edward G. BroennimanDirector4,3130.61%Oct 15, 2026
Angela RossettiDirector4,8460.68%Oct 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Steven P. Larosa
Chief Medical Officer
Oct 8, 2026Award+42,000––42,057
James B. Frakes
CFO/CEO, Director
Oct 8, 2026Award+42,000––42,063
Chetan Shah
Director
Sep 30, 2026Tax withholding−436$6.52$2.84K3,787
Nicolas Gikakis
Director
Sep 30, 2026Tax withholding−436$6.52$2.84K3,784
Edward G. Broenniman
Director
Sep 30, 2026Tax withholding−218$6.52$1.42K4,313
Edward G. Broenniman
Director
Jun 30, 2026Tax withholding−1,091$0.82$89522,363
Nicolas Gikakis
Director
Jun 30, 2026Tax withholding−2,182$0.82$1.79K20,663
Chetan Shah
Director
Jun 30, 2026Tax withholding−2,182$0.82$1.79K20,840
Angela Rossetti
Director
Apr 17, 2026Award+21,815$2.29$49.96K4,846
Edward G. Broenniman
Director
Apr 17, 2026Award+21,815$2.29$49.96K23,454
Angela Rossetti
Director
Apr 17, 2026Award+21,815$2.29$49.96K26,207
Chetan Shah
Director
Apr 17, 2026Award+21,815$2.29$49.96K23,021
Nicolas Gikakis
Director
Apr 17, 2026Award+21,815$2.29$49.96K22,844
Chetan Shah
Director
Mar 31, 2026Tax withholding−178$2.19$3901,463
Nicolas Gikakis
Director
Mar 31, 2026Tax withholding−178$2.19$3901,464
Edward G. Broenniman
Director
Mar 31, 2026Tax withholding−89$2.19$1951,915
Edward G. Broenniman
Director
Dec 31, 2025Tax withholding−89$2.77$2472,807
Nicolas Gikakis
Director
Dec 31, 2025Tax withholding−179$2.77$4962,357
Chetan Shah
Director
Dec 31, 2025Tax withholding−179$2.77$4962,356
Edward G. Broenniman
Director
Sep 30, 2025Tax withholding−893$0.75$67025,397
Chetan Shah
Director
Sep 30, 2025Tax withholding−1,786$0.75$1.34K22,672
Nicolas Gikakis
Director
Sep 30, 2025Tax withholding−1,786$0.75$1.34K22,683
Edward G. Broenniman
Director
Jun 30, 2025Tax withholding−893$1.20$1.07K21,825
Nicolas Gikakis
Director
Jun 30, 2025Tax withholding−1,786$1.20$2.14K20,004
Chetan Shah
Director
Jun 30, 2025Tax withholding−1,786$1.20$2.14K19,993
Angela Rossetti
Director
Apr 23, 2025Award+142,857$0.35$50.00K343,400
Nicolas Gikakis
Director
Apr 23, 2025Award+142,857$0.35$50.00K174,320
Chetan Shah
Director
Apr 23, 2025Award−142,857$0.36$51.43K174,233
Edward G. Broenniman
Director
Apr 23, 2025Award+142,857$0.35$50.00K181,741
Edward G. Broenniman
Director
Mar 31, 2025Tax withholding−1,645$0.36$59238,884
Chetan Shah
Director
Mar 31, 2025Tax withholding−3,289$0.36$1.18K31,376
Nicolas Gikakis
Director
Mar 31, 2025Tax withholding−3,289$0.36$1.18K31,463
Nicolas Gikakis
Director
Dec 31, 2024Tax withholding−3,289$0.86$2.83K34,752
Chetan Shah
Director
Dec 31, 2024Tax withholding−3,289$0.86$2.83K34,665
Edward G. Broenniman
Director
Dec 31, 2024Tax withholding−1,645$0.86$1.41K40,529
Edward G. Broenniman
Director
Sep 30, 2024Tax withholding−1,645$0.47$77342,174
Chetan Shah
Director
Sep 30, 2024Tax withholding−3,289$0.47$1.55K37,954
Nicolas Gikakis
Director
Sep 30, 2024Tax withholding−3,289$0.47$1.55K38,041
Edward G. Broenniman
Director
Jun 28, 2024Tax withholding−1,645$0.50$82343,819
Chetan Shah
Director
Jun 28, 2024Tax withholding−3,289$0.50$1.64K41,243
Nicolas Gikakis
Director
Jun 28, 2024Tax withholding−5,244$0.50$2.62K41,330
Edward G. Broenniman
Director
Apr 16, 2024Award+32,894$1.52$50.00K45,464
Nicolas Gikakis
Director
Apr 16, 2024Award+32,894$1.52$50.00K46,574
Angela Rossetti
Director
Apr 16, 2024Award+32,894$1.52$50.00K200,543
Chetan Shah
Director
Apr 16, 2024Award+32,894$1.52$50.00K44,532
Nicolas Gikakis
Director
Mar 29, 2024Tax withholding−1,954$1.68$3.28K13,680
Edward G. Broenniman
Director
Mar 29, 2024Tax withholding−1,163$1.68$1.95K12,570
Chetan Shah
Director
Mar 29, 2024Tax withholding−1,163$1.68$1.95K11,638
Chetan Shah
Director
Dec 29, 2023Tax withholding−1,163$2.19$2.55K12,801
Edward G. Broenniman
Director
Dec 29, 2023Tax withholding−1,163$2.19$2.55K13,733
Nicolas Gikakis
Director
Dec 29, 2023Tax withholding−1,954$2.19$4.28K15,634
Edward G. Broenniman
Director
Sep 29, 2023Tax withholding−11,628$0.23$2.67K148,957
Nicolas Gikakis
Director
Sep 29, 2023Tax withholding−19,541$0.23$4.49K175,873
Chetan Shah
Director
Sep 29, 2023Tax withholding−11,628$0.23$2.67K139,637
Nicolas Gikakis
Director
Jul 3, 2023Award+195,414––195,414
Chetan Shah
Director
Jun 30, 2023Tax withholding−11,628$0.36$4.19K151,265
Edward G. Broenniman
Director
Jun 30, 2023Tax withholding−11,628$0.36$4.19K160,585
Chetan Shah
Director
Apr 28, 2023Award+116,279––162,893
Angela Rossetti
Director
Apr 28, 2023Award+116,279––167,649
Edward G. Broenniman
Director
Apr 28, 2023Award+116,279––172,213

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
7.08%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+31.2%
From 0M shares
Short volume, 20 days
40.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aethlon Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 246,697 shares on Sep 18, 2026 over the last 90 days.

See a number that looks wrong?